ScripPharma executives no longer ask whether AI is important in their industry – that much is certain, and it is already ubiquitous. As Lamine Mbow , global head of discovery research at Boehringer Ingelh
ScripPierre Fabre has moved fast to secure the rights to Atara Biotherapeutics, Inc. 's tabelecleucel, just days after the off-the-shelf T-cell therapy got the green light to be fast-tracked by regulator
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Teams With Precision On DMD, Gene